(THC) Tenet Healthcare - Ratings and Ratios

Tenet Healthcare Corporation is a diversified healthcare services provider in the United States, operating through two main segments: Hospital Operations and Services, and Ambulatory Care. The companys general hospitals offer a wide range of acute care services, including operating and recovery rooms, radiology, and respiratory therapy, as well as specialized services such as cardiovascular, neurosciences, and obstetrics. Additionally, Tenet provides tertiary care services like cardiothoracic surgery, neonatal intensive care, and neurosurgery, and quaternary care services including heart, liver, and kidney transplants.

The companys extensive network includes hospitals, ambulatory surgery centers, urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals, providing a broad array of procedures and services such as orthopedics, gastroenterology, pain management, and urology. With a presence across the US, Tenet Healthcare Corporation has established itself as a significant player in the healthcare industry, leveraging its scale and expertise to drive growth and innovation.

Analyzing the companys , we observe that the stock has reached its 52-week high of $171.84, with a 20-day SMA of $163.54, indicating a strong upward trend. The ATR of 5.37, representing a 3.12% daily volatility, suggests that the stock is experiencing significant price movements. Considering the , Tenet Healthcare Corporations market capitalization stands at $15.14 billion, with a P/E ratio of 10.45 and a forward P/E of 13.72, indicating a relatively undervalued stock with potential for growth.

Combining the insights from and , we can forecast that Tenet Healthcare Corporations stock is likely to continue its upward trend, driven by the companys strong operational performance and favorable industry trends. With a RoE of 37.16, indicating high profitability, and a relatively low P/E ratio, the stock presents an attractive investment opportunity. Our forecast suggests that the stock may reach $185 in the near term, representing a 7.5% increase from the current price, driven by the companys continued growth and expansion in the healthcare services market.